Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Intraportal Infusion in Liver Transplant
NCT00609388Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2008
- Primary completion
- Dec 2010
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemia-reperfusion injury (IRI) comparing Tacrolimus Infusion with Placebo Infusion (2 arms). Primary endpoints: Aspartate Aminotransferase at Week 12, Alanine Aminotransferase at Week 12 and 4 more. Started Jan 2008; status: completed.
02
Drugs
tacrolimus
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00609388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609388.